Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 6 studies | 23% ± 6% | |
| astrocyte | 4 studies | 23% ± 3% | |
| endothelial cell | 3 studies | 20% ± 5% | |
| epithelial cell | 3 studies | 31% ± 10% | |
| type II pneumocyte | 3 studies | 20% ± 5% | |
| GABAergic neuron | 3 studies | 23% ± 6% | |
| hepatocyte | 3 studies | 29% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 3111.00 | 226 / 226 | 100% | 23.48 | 406 / 406 |
| thymus | 100% | 3048.41 | 653 / 653 | 100% | 25.91 | 605 / 605 |
| brain | 100% | 2664.91 | 2639 / 2642 | 100% | 19.09 | 705 / 705 |
| ovary | 100% | 2406.98 | 180 / 180 | 100% | 21.44 | 429 / 430 |
| prostate | 100% | 3566.20 | 245 / 245 | 100% | 24.60 | 500 / 502 |
| adrenal gland | 100% | 2054.28 | 258 / 258 | 100% | 13.18 | 229 / 230 |
| pancreas | 100% | 2535.56 | 328 / 328 | 99% | 17.25 | 177 / 178 |
| intestine | 100% | 2472.84 | 966 / 966 | 99% | 16.64 | 523 / 527 |
| skin | 100% | 1329.36 | 1806 / 1809 | 99% | 12.87 | 469 / 472 |
| uterus | 100% | 2612.47 | 170 / 170 | 99% | 18.05 | 453 / 459 |
| breast | 100% | 1678.36 | 459 / 459 | 99% | 19.57 | 1103 / 1118 |
| bladder | 100% | 2397.05 | 21 / 21 | 98% | 16.95 | 496 / 504 |
| esophagus | 100% | 2288.04 | 1445 / 1445 | 98% | 13.95 | 180 / 183 |
| lung | 100% | 1856.78 | 576 / 578 | 99% | 15.51 | 1139 / 1155 |
| stomach | 100% | 2365.40 | 359 / 359 | 98% | 16.82 | 280 / 286 |
| kidney | 100% | 1936.35 | 89 / 89 | 98% | 10.91 | 882 / 901 |
| eye | 0% | 0 | 0 / 0 | 100% | 11.61 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.38 | 29 / 29 |
| spleen | 100% | 1796.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.97 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.97 | 1 / 1 |
| blood vessel | 100% | 1835.31 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1281.18 | 856 / 861 | 0% | 0 | 0 / 0 |
| adipose | 99% | 1218.99 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 98% | 978.01 | 789 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 945.23 | 805 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF444 |
| Protein name | Zinc finger protein 444 (Endothelial zinc finger protein 2) (EZF-2) (Zinc finger and SCAN domain-containing protein 17) Zinc finger protein 444 |
| Synonyms | ZSCAN17 EZF2 |
| Description | FUNCTION: Transcriptional regulator. Binds to the 5'-flanking critical region of the SCARF1 promoter. |
| Accessions | K7EJ91 ENST00000587467.5 K7ELZ3 ENST00000591564.1 ENST00000588358.5 K7EMV5 K7EK55 ENST00000588203.1 ENST00000586123.5 ENST00000337080.8 [Q8N0Y2-1] Q8N0Y2 K7ESL2 K7EJH4 ENST00000593100.5 ENST00000592949.5 [Q8N0Y2-2] |
